Cellectis Inc. (CLLS) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cellectis S.a..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.514 Please stand by. Your program is about to begin. 00:00:02.514 -- 00:00:08.820 If you need audio assistance during today's program, please press star zero. 00:00:10.866 -- 00:00:15.032 Good day, everyone, and welcome to today's Selectus full year 2024 earnings conference 00:00:15.032 -- 00:00:18.397 call. At this time, all participants are in a listen-only mode. 00:00:18.397 -- 00:00:22.122 Later, you will have the opportunity to ask questions during the question and answer 00:00:22.122 -- 00:00:26.708 session. You may register to ask a question anytime by pressing the star, then the one 00:00:26.708 -- 00:00:30.952 key on your telephone keypad. You may withdraw yourself from the queue by pressing the 00:00:30.952 -- 00:00:34.979 star 2 key. Please note, today's conference is being recorded. 00:00:34.979 -- 00:00:37.824 I will be standing by if you should need any assistance. 00:00:37.824 -- 00:00:40.729 It is now my pleasure to turn the conference over to Arthur Strill. 00:00:40.729 -- 00:00:43.130 Please go ahead. 00:00:44.296 -- 00:00:49.565 Good morning, and welcome, everyone, to Selectus' fourth quarter and full year 2024 00:00:49.565 -- 00:00:53.491 business update and financial results conference calls. 00:00:53.491 -- 00:00:58.338 Joining me on the call today are Dr. André Choulika, our Chief Executive Officer, and 00:00:58.338 -- 00:01:02.324 Dr. Adrienne Kilcoyne, our Chief Medical Officer. 00:01:02.324 -- 00:01:07.352 Yesterday evening, Selectus issued a 6K and press release reporting our financial statements 00:01:07.352 -- 00:01:11.759 for the 12-month period ended December 31, 2024, 00:01:11.759 -- 00:01:16.847 and a business update. The report and press release are available on our website at 00:01:16.847 -- 00:01:18....